Archives for category: libertarian politics

This blog is about what interests me. What interest me falls into a general pattern.

Lets read the tea leaves for Bioelectronics. I’m doing this for the non-obsessives. I’ve learned that some things I take for granted logically do not always follow naturally for others. So this is for people interested in BIEL.

  1. The last time Keith Nalepka was on the radio, he said he would be back within forty days with news, basically about the Dr. Scholls deal getting finalized.
  2. Premise-the Dr. Scholls deal can’t get finalized until General Clearance for Pain is granted by the FDA, along with with the wound healing application. This will make the deal better, and will be what the ad campaign is based on. So Bayer/Dr. Scholls needs this before this goes live.
  3. Two days ago, Keith Nalepka said he would be on the radio within the next three weeks.
  4. Sum= Keith Nalepka expects to get General Clearance within the next three weeks, and to be on the radio discussing the Dr. Scholls deal, finalized.
  5. So, General Clearance within the next three weeks?

Steps 1-5 make sense to me. If Nalepka committed to the radio talk, read between the lines.

A general comment—I expect wound care to be easier than general muscle pain, data wise. People are wooses. I don’t expect an honest answer about pain from most people. It’s tough to gauge. Given enough cases in a well run study, yes, you can generate valid data, but I innately am suspicious of gripers.

Wound care, however, is a beautiful study. Just take a thousand similar wounds, treat 500 with an ActiPatch and 500 with a placebo, monitor objective criteria like healing time, swelling dissipation, scar formation, rate of infection, there are multitudes of data you can can chart, graph, correlate. Now you’re talking my language. How do you feel doesn’t work for me, especially when half the people in the study might just be whiny crybabies who want an opioid prescription.

Why do you think the German giant medical stock BRAUN like BIEL for it’s wound treatment in that recent major deal? Because you can prove wound healing with data with no debate really.

Anyway, it will be interesting to see how it plays out. I have to thank Keith Nalepka for his transparency on Twitter. Follow him, let’s make him a Blue Check.  Expect a press release next week as yet another European country announced it will pay for the Actipatch. Sweden, which has one of the greatest health care programs in the world, joined the UK in adding Actipatch to their national health care program. I thought Germany would be next in line because of BRAUN, but I will take Sweden, a world leader. It is exciting to see all this finally playing out.  I’m rooting for Andrew Whelan and the team. It’s like the Old Man and The Sea, as  I have said before. He caught the biggest fish in the world, and for all the BIEL shareholder’s sakes I hope he can bring it home. Something tells me the sharks already had their best chance.





Link here:


My  thought is why BIEL should have to wait until November for FDA General Clearance so the FDA can take credit for “developing” them. The FDA ground an spiked jackboot into the faces of this company, its investors, and this technology. Now they want to stall us so they can take political credit? This is bullshit. General Clearance could take place on Monday, and should. This stalling tactic by the FDA is a sign of desperation and panic by those pillpushers as one of their pharmaceutical pimp masters prepares to unleash a new drug treatment for migraines.

BIEL has disruptive technology. So what? It is better for people. The FDA needs to get their house in order and perform their stated (supposed) primary function: ” Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation….FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health…”

The FDA does not need to “mold” BIEL. BIEL educated them, literally, into two clearances and now needs the third one (Back) to get the General Clearance, the world’s first electronic aspirin.

The Democrats are out of power, and Trump is going to run a clean game so he wins a second term, then we’ll see.  In other words, there is a new sheriff, and he will be around until 2024 unless some piece of shit establishment thug gang assassinates him they way they murdered the Kennedy brothers. Deal with it. BIEL only needs you to do your jobs, now, not some bullshit program designed to hide the fact that the FDA murdered millions with opioids.

Updated 6-4-18

I figured I may as well just ask somebody at Bioelectronics about this issue, and thanks to Keith Nalepka for a prompt reply on Twitter. I have a deep distrust of the FDA process, having been a longtime shareholder. My next question would be if the FDA gives General Clearance now, what exactly will they do for BIEL in November? The free market will fuel further research and development once the FDA does its job and provides General Clearance. This FDA program sounds great, and would have been an especially amazing idea ten years ago. It’s as if the opioid crisis started on the day Trump was inaugurated.  The whole thing smacks of political opportunism, a quest by the FDA to stay relevant as they got outdone by other regulatory agencies around the world. BIEL did this without the FDA’s help, indeed, with the FDA’s active resistance. I put the pieces of that puzzle together a long time ago, on this blog (see Margaret Hamburg and the Renaissance Hedge Fund). Not a pretty picture. All BIEL needs from the FDA is General Clearance for Pain and then timely review of other applications, such as Migraine.

Note–I have nothing to do with this company except I bought some shares. If somebody from the FDA reads this and decides to get revenge, all they will really be punishing are sufferers from pain. I don’t matter. I am simply not the forgiving type. A lot of people could have been helped if the FDA had been an honest agency in the Obama era instead of a slush fund for Hillary’s political cronies.

Anyway, thanks again for the reply, it made sense.

Screenshot 2018-06-04 at 7.47.19 AM - Edited.png


I learned a new word yesterday, or at least realized my previous definition was subpar: “astroturfing”. Sharyl Attkisson gave a talk about it.

Ms. Attkisson is the reason I usually say 99% of all media are corrupt liars. She is a one percenter.  There are a few I like.  She is famous for exposing the dark side of the 2008 bank bailouts (was there a light side?), and also for exposing Hillary Clinton’s “sniper on the tarmac in Bosnia” lie.  More relevant to today, she is also famous for accusing Obama of hacking her computer and cellphone. This does indicate a behavioral pattern, if you follow the story about Trump’s campaign getting infiltrated Watergate style by Obama’s crew.

Please watch the video below. I call such videos “Anti-Idiocracy” moments. Briefly, “Grassroot” movements are genuinely organic social movements that spring up from actual human beings spontaneously, reminiscent of mass migrations of the serfs Tolstoy wrote about. Astroturfing is when a fake stage is set for a fake movement.

Attkisson is mainly speaking about the pharmaceutical industry, but it does not require much imagination to apply her principle to anything, any product, politician, or political push.

Note: I am a long term proponent of a product and company, ActiPatch and the Bioelectronics Corporation. I am an investor, and my blog deals with this quite a bit especially lately. I must ask myself, am I grassroots or astroturf? It is legitimate as a question. My answer is my book, Zombie World Order, in which I deal extensively with my views on the corruption and dangers of the opioid industry. 8 positive reviews and one asshole from Twitter who didn’t read the book. Buy it, it will change your life and mine as well, because then I will be a fourdollaraire. Yippee!!


Okay, so my post about BIEL on Twitter sort of got upstaged here. This got picked up by Yahoo pretty quick. I will do the math for you–7x 160,000=1,120,000 units a years just got sold. I had to ask the Gifted kid to do the math for me, because I can’t do math when I get giddy.

Also, FDA, put this in your pipe and smoke it. Next step is Germany announces it will reimburse for the ActiPatch the way the United Kingdom has through its NHS. The FDA better get it in gear. Margaret Hamburg, the Renaissance Hedge Fund, Hillary’s grifting out FDA top slots to her political stooges—those days are over. Trump doesn’t know enough about how government really works to know how much money he is leaving on the table by not taking the opioid payoff money. Hillary never would have let this happen.



B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program


FREDERICK, MD., May 31, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed development of its same day surgical TOTAL Pathway program for joint replacements which includes BioElectronics medical devices. The program is being launched by B. Braun’s UK Group to improve care and reduce the UK healthcare cost of its 160,000 annual hip and knee replacement procedures.

The “fast-track” same day hip and knee replacements are being supported by hospital physiotherapy teams visiting the patient at home and communicating using a specialized wireless tablet. Each patient will be given an ActiPatch medical device and a prescription for 6 additional ActiPatch devices. A similar program is being implemented for spinal surgeries.

Phil Cleary, Senior Product Group Manager, stated that “our TOTAL Pathway program enhances our commitment to patient safety, post-operative care, as well as significantly reducing healthcare costs and hospital stays.” Treating post-surgical pain requires a multifaceted approach. In trials, ActiPatch was well received and produced positive outcomes. We look forward to making this program a success, in the UK and other countries where B. Braun operates.

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit

About B. Braun Medical Ltd B. Braun Medical Ltd, UK, is a member of the B. Braun Group, one of the world´s leading healthcare companies. On an international level, B. Braun’s 54,000 employees are in 60 countries and are separated into additional divisions for hospital care, surgical products, outpatient care, and home care services.

First off, congratulations to the IHUB BIEL board, which is approaching 1000 followers. I admire many of the people who post there, although I am not a member myself. I am leery of the negative emotions the social media circus triggers, and since I would most likely be banned in about 5 minutes, it’s pointless.

I do thank the long time posters there, many of whom I have linked to on this blog so readers here could benefit.

However, let’s face a sobering truth, nobody really knows about the ActiPatch. It has never “gone viral”. We’ve had a couple of nibbles, and a lot of people who were desperate and seeking pain relief stumbled on to it, and that is a big part of why Bioelectonics (BIEL) is still a story. The ActiPatch works.

Also, nobody really knows about this company. Everyone is in the market, but this is usually through a 401K plan. Nobody buys subpennies. Your broker will laugh at you. He is paid to laugh at you. It’s a total sheeple mentality. If you can remember 2008, when all the “smart money” stocks got obliterated due to widespread economic fraud, you may take “smart money” with a grain of salt. We need to get more shareholders for this value based stock with a great pipeline and concept.

So, we have a relatively unknown product and a relatively unknown stock, after years of noble effort on IHUB by some of the best, smartest, and most creative people on the Internet.

Where am I going?

Fidget Spinners.

Yes, you read that right. I had never heard of a Fidget Spinner in my life until Baron Trump (what a name) got off the Presidential helicopter playing with a fidget spinner. Suddenly they were everywhere, gas stations had them, quickie marts, etc.

Twitter did that. Baron went viral on Twitter and other social media and fidget spinners became a thing.

So, get on Twiter and follow Bioelectronic VP of Sales Keith Nalepka. He gets it. Follow all the Bioelectronic people, and retweet their news announcements. You will find this rewarding–these are very smart people. Also, there are multitudes of people sincerely trying to get relief from pain safely.

I don’t know how many people are on Twitter. A hundred million? For the loyal IHUBers–the best day of our investment lives is when we finally lose any control over this stock and technology. There have been days when I have had a good percentage of the stock’s volume–how is that even possible? So, lets get behind Nalepka’s effort and start pushing this on Twitter.

Keith Nalepka Retweeted

we have been innovating, look paid for by the NHS in the UK, proven in trials to lower medication use, fewer doctor visits, sold in 29 countries, its time for the US market to see the light, large retailers are taking notice, oh and its OTC.

Keith Nalepka added,

Not a great day. Weak sales translated into an opportunity for people to short the stock to the tune of a 25% drop.

Not pleasant, but wasn’t this whole run up fueled by a  short squeeze on traders who were caught by surprise when the NHS announced subsidized payments on the ActiPatch? These guys make the market.

The expression “keep your eye on the prize”. Where you want to be on the day the FDA announces General Clearance is  sitting on a couple million shares of BIEL. The first two FDA clearances were not long after a successful FDA meeting. This is where the new lawyers for BIEL explained to the FDA why the ActiPatch should be OTC.

As per Andrew Whelan, once BIEL gets that third clearance (Back) this will translate into a General Clearance. General Clearance is your money melon, and the main reason I am troubling myself to hold on to this stock.

Let’s see what BIEL has to say after the May 29th FDA meeting. 8 trading days left till it, then maybe 2 to develop a press release.

After this stock hits, the next stop is physical silver. I mean to stay poor, even after I get rich.  Poverty is your treasure, don’t lose it, as the Buddhist koan goes. Silver is a ticking time bomb.  The Implosion in 2008 was partially fueled by the wheels coming off the silver rig. Buying mining stocks is pointless. Just get physical.  Plus, BIEL has taught me something–I hate the stock market. I aim to get rid of that third party risk.

Since JP Morgan will be rigging silver for the foreseeable future, I can wait for BIEL to outwait the FDA, who must eventually run out of excuses. I think TENS has more at stake in stopping BIEL then the dreaded Opioid cartel at this point.

Winding up May 15th, 2018.  Bioelectronics will most likely release a statement about the May 29th FDA meeting by June 1st, 2018.  While BIEL cannot comment on the General Clearance meeting which took place on May 9th (or so) while in process, it might well provide some hints included in the May 29th release on the separate FDA application for wound healing. This would be the tactful way.

Waiting for  the “ink to dry” on the Doctor Scholl’s agreement. I have a pen here at home I could have lent them, usually  dries completely in about thirty seconds. I admit it is not a very special pen, I think I lifted it from a bank, but I would have been happy to donate it, for future reference.